Synthesis, biological evaluation, and molecular docking of N'-(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives

A series of new N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazide derivatives were synthesized. Starting from ethyl piperidine-4-carboxylate (a), first ethyl 1-(phenylsulfonyl)piperidine-4-carboxylate (1), second 1-(phenylsulfonyl)piperidine-4-carbohydrazide (2), and finally N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazides (4a--n) were synthesized by reacting 2 with alkyl/aryl sulfonyl chlorides (3a--n). The structures of the synthesized compounds were characterized by IR, 1H-NMR, and EI-MS spectra and all were screened in vitro for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzyme inhibition activities. Molecular docking was accomplished for these compounds to examine their binding interactions with AChE and BChE human proteins. The strategy we applied for this purpose was a direct receptor-based approach. The binding modes of the inhibitors under study were determined using an automated docking program (AutoDock) and were compared with antienzymatic IC50 values. Both studies confirmed the potential of compounds as excellent inhibitors for AChE and BChE.

Synthesis, biological evaluation, and molecular docking of N′ -(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives

A series of new N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazide derivatives were synthesized. Starting from ethyl piperidine-4-carboxylate (a), first ethyl 1-(phenylsulfonyl)piperidine-4-carboxylate (1), second 1-(phenylsulfonyl)piperidine-4-carbohydrazide (2), and finally N'-[(alkyl/aryl)sulfonyl]-1-(phenylsulfonyl)piperidine-4-carbohydrazides (4a--n) were synthesized by reacting 2 with alkyl/aryl sulfonyl chlorides (3a--n). The structures of the synthesized compounds were characterized by IR, 1H-NMR, and EI-MS spectra and all were screened in vitro for their acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzyme inhibition activities. Molecular docking was accomplished for these compounds to examine their binding interactions with AChE and BChE human proteins. The strategy we applied for this purpose was a direct receptor-based approach. The binding modes of the inhibitors under study were determined using an automated docking program (AutoDock) and were compared with antienzymatic IC50 values. Both studies confirmed the potential of compounds as excellent inhibitors for AChE and BChE.

___

  • Massoulie, J.; Pezzementi, L.; Bon, S.; Krejci, E.; Valette, F. M. Prog. Neurobiol. 1993, 41, 31–91.
  • Chatonnet, A.; Lockridge, O. Biochem. J. 1989, 260, 625–634.
  • C ¸ oku˘ gra¸s, N. A. Turk. J. Biochem. 2003, 28, 54–61.
  • Sussman, L. J.; Harel, M.; Frolow, F.; Oefner, C.; Goldman, A.; Toker, L.; Silman, I. Protein Sci. 1991, 253, 872–878.
  • Gilman, A. G.; Rall, T. W.; Nies, A.; Taylor, P. In The Pharmacological Basis of Therapeutics; Eds. Pergamon, New York 1990, pp. 131–149.
  • Hallak, M.; Giacobini, E. Neuropharmacology 1989, 28, 199–206.
  • Scarpini, E.; Scheltens, P.; Feldman, H. Lancet Neurol. 2003, 2, 539–547.
  • Perry, E. K.; Tomlinson, B. E.; Blessed, G.; Bergman, K.; Gibson, P. H.; Perry, R. H. Brit. Med. J. 1978, 25, 1457–1459.
  • Holzgrabe, U.; Kapkova, P.; Alptuzun, V.; Scheiber, J.; Kugelmann, E. Expert. Opin. Ther. Targets 2007, 11, 161–179.
  • Butini, S.; Campiani, G.; Borriello, M.; Gemma, S.; Panico, A.; Persico, M.; Catalanotti, B.; Ros, S.; Brindisi, M.; Agnusdei, M.; et al. J. Med. Chem. 2008, 51, 3154–3170.
  • Bartolini, M.; Bertucci, C.; Cavrini, V.; Andrisano, V. Biochem. Pharmacol. 2003, 65, 407–416.
  • Shafferman, A.; Velan, B.; Ordentlich, A.; Kronman, C.; Grosfeld, H.; Leitner, M.; Flashner, Y.; Cohen, S.; Barak, D.; Ariel, N. EMBO J. 1992, 11, 3561–3568.
  • Changeux, J. P. Mol. Pharmacol. 1966, 2, 369–392.
  • Cochard, P.; Coltey, P. Dev. Biol. 1983, 98, 221–238.
  • Chatonnet, A.; Lockridge, O. Biochem. J. 1989, 260, 625–634.
  • Sikorav, J. L.; Krejci, E.; Massoulie, J. EMBO J. 1987, 6, 1865–1873.
  • Solis, A.; Nava, A.; Perez, H. I.; Manjarrez, N.; Luna, H.; Cassani, J. J. Mex. Chem. Soc. 2008, 52, 181–184. Khalid, H. Aziz-ur-Rehman; Abbasi, M. A.; Khan, K. M. Int. J. Pharm. Pharm. Sci. 2012, 4, 443–448.
  • Aziz-ur-Rehman; Nafeesa, K.; Abbasi, M. A.; Khalid, H.; Khan, K. M.; Ashraf, M.; Ahmad, I.; Ejaz, S. A. Asian. J. Pharm. Hea. Sci. 2012, 2, 370–376.
  • Aziz-ur-Rehman; Siddiqui, S. Z.; Abbas, N.; Abbasi, M. A.; Khan, K. M.; Shahid, M.; Mahmood, Y.; Akhtar, N. M.; Lajis, N. H. Int. J. Pharm. Pharm. Sci. 2012, 4, 676–680.
  • Ellman, G. L.; Courtney, K. D.; Andres, V.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88–95.
  • Kryger, G.; Harel, M.; Giles, K.; Toker, L.; Velan, B.; Lazar, A.; Kronman, C.; Barak, D.; Ariel, N.; Shafferman, A.; et al. Acta. Crystallogr. D. 2000, 56, 1385–1394.
  • Pettersen, E. F.; Goddard, T. D.; Huang, C. C.; Couch, G. S.; Greenblatt, D. M.; Meng, E. C.; Ferrin, T. E. J. Comput. Chem. 2004, 25, 1605–1612.
  • Humphrey, W.; Dalke, A.; Schulten, K. J. Mol. Graphics 1996, 14, 33–38.
  • Allouche, A. R. J. Comput. Chem. 2010, 32, 174–182.
  • Stewart, J. P. J. Mol. Model. 2007, 13, 1173–1213.
  • Trott, O.; Olson, A. J. J. Comput. Chem. 2010, 31, 455–461.
  • Deng, X; Mani, N. S. Green Chem. 2006, 8, 835–838.
  • Jafarpour, M; Rezaeifard, A; Golshani, T. J. Phosphorous, Sulfur and Silicon. 2011, 186, 140–148.
  • Aziz-ur-Rehman; Afroz, S; Abbasi, M. A; Tanveer, W; Khan, K. M; Asraf, M; Afzal, I; Ambreen. Pak. J. Pharm. Sci. 2012, 25, 809–814.
  • Aziz-ur-Rehman; Rasool, S; Abbasi, M. A; Khan, K. M; Asraf, M.; Afzal, I. Asian J. Phram. Bio. Res. 2012, 2, 100–105.
  • Aziz-ur-Rehman; Awais-ur-Rehman; Abbasi, M. A; Khalid, H; Khan, K. M; Dar, P. Asian J. Pharm. Hea. Sci. 2012, 2, 384–389.
Turkish Journal of Chemistry-Cover
  • ISSN: 1300-0527
  • Yayın Aralığı: 6
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Selective synthesis of cyclododec-2-en-1-yl ethers via palladium-catalyzed allylic substitution reaction: a kinetic study

Asen KOLEV, Magdalena MITKOVA, Stefan KOTOV, Encho BALBOLOV

Synthesis and characterization of new (E)-N'-(substituted benzylidene)-2-(3-(2-methyl)-4-oxo-3,4-dihydroquinazolin-2-ylthio)acetohydrazides

Aamer SAEED, Shams-ul MAHMOOD, Ulrich FLÖRKE

Spectrophotometric determination of molybdenum using surfactant-mediated liquid--liquid extraction

Rameshwar DASS, Jitander Kumar KAPOOR, Sunita GAMBHIR

Calixpenams: synthesis, characterization, and biological evaluation of penicillins V and X clustered by calixarene scaffold

Fazel NASUHI PUR, Karim AKBARI DILMAGHANI

Spectrophotometric determination of molybdenum using surfactant-mediated liquid liquid extraction

Rameshwar DASS, Jitander Kumar KAPOOR, Sunita GAMBHIR

Speciation of chromium by the combination of dispersive liquid--liquid microextraction and microsample injection flame atomic absorption spectrometry

Yunus Emre ÜNSAL, Mustafa TÜZEN, Mustafa SOYLAK

Synthesis, biological evaluation, and molecular docking of ′ N -(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives

Rashad HUSSAIN, Khalid MOHAMMAD KHAN, Muhammed ASHRAF, Syeda Abida EJAZ, Muhammad Qaiser FATMI, Hira KHALID, Aziz UR REHMAN, Muhammad Athar ABBASI

Optimization of LiFePO4 synthesis by hydrothermal method

Muhsin MAZMAN, Ömür ÇUHADAR, Davut UZUN, Ercan AVCI

Aryl butenoic acid derivatives as a new class of histone deacetylase inhibitors: synthesis, in vitro evaluation, and molecular docking studies

Peruze AYHAN EŞİYOK, Özlem SEVEN, Gülüzar EYMUR, Gamze BORA TATAR, Didem DAYANGAÇ ERDEN, Kemal YELEKÇİ, Hayat YURTER, Ayhan Sıtkı DEMİR

Platinum or nickel nanoparticles decorated on silica spheres by microwave irradiation technique

Ayşe BAYRAKÇEKEN